29 citations
,
February 2016 in “International Journal of Dermatology” This study found that patients with lichen planus were significantly more likely to have dyslipidemia, particularly with higher triglyceride levels.
12 citations
,
October 2019 in “Aesthetic Plastic Surgery”
7 citations
,
May 2022 in “International Journal of Environmental Research and Public Health” This study found that isotretinoin therapy for acne vulgaris typically causes mild mucocutaneous adverse events, which are reversible and vary individually.
4 citations
,
May 2019 in “The World Journal of Men's Health” This study found no significant increase in depression risk associated with taking five-alpha reductase inhibitors for benign prostatic hyperplasia or alopecia, although further studies are needed to confirm these findings.
1 citations
,
August 2018 in “Journal of the American Academy of Dermatology” This study found that vitamin D levels in children with autoimmune alopecia were often below optimal, but did not suggest a need for extra vitamin D screening beyond standard practices.
July 2026 in “Journal of the American Academy of Dermatology” This study found that patients with alopecia areata have a significantly higher risk of retinal abnormalities, suggesting common immune mechanisms, though the low absolute risk indicates that screening should be led by symptoms rather than done routinely.
July 2026 in “Journal of the American Academy of Dermatology” January 2026 in “Zenodo (CERN European Organization for Nuclear Research)” This study reviews classical Ayurvedic texts and modern research on Amalaki, finding significant benefits for lipid profiles, blood glucose, and inflammation in clinical trials, while also suggesting potential benefits for liver, hair, skin, eyes, cognition, and respiratory health based on preclinical data and traditional claims.
January 2026 in “Zenodo (CERN European Organization for Nuclear Research)” This research highlights that Amalaki demonstrates cardiometabolic and hepatic benefits in human trials, while narrative synthesis of preclinical studies suggests promise in hair, skin, ocular, cognitive, and respiratory health.
This article reviews the potential link between male androgenetic alopecia and metabolic syndrome, noting the lack of conclusive evidence establishing an association.
The document plans to assess if Xiao-Chai-Hu-Tang is effective for chronic fatigue syndrome but has no results yet.
September 2018 in “Value in Health” This umbrella review found that Turmeric may improve outcomes for knee osteoarthritis, depression, and metabolic syndrome, but the evidence is weak due to small sample sizes.
October 2017 in “The Journal of Urology” This review discusses the impact of 5α-reductase inhibitors on sexual function and presents results from a meta-analysis of randomized controlled trials, without reporting new clinical findings.
March 2014 in “Journal of The American Academy of Dermatology” Terbinafine 250 mg is the most effective treatment for fungal nail infections.
February 2010 in “Journal of The American Academy of Dermatology” This study found that nonobese women with idiopathic hirsutism had significantly lower nitrite/nitrate concentrations and higher fibrinogen levels compared to controls, but similar levels to women with PCOS.
Results are not reported in this abstract, but it outlines the objective to evaluate the efficacy of microneedling, alone and in combination with other treatments, for pattern hair loss through a systematic review and meta-analysis.
66 citations
,
June 2013 in “Journal of Dermatological Treatment” This study reported no significant difference in efficacy or sexual dysfunction risk between 5α-reductase inhibitors and placebo for androgenetic alopecia, suggesting that dutasteride 0.5 mg may be considered pending further research.
31 citations
,
January 2019 in “Journal of Cutaneous Medicine and Surgery” This review found that three monthly PRP injections improved hair density in patients with androgenetic alopecia compared to placebo, but more rigorous studies are needed for broader dermatological applications.
21 citations
,
January 2019 in “Lasers in Medical Science” This review found that low-level laser therapy significantly increased hair density in adults with androgenic alopecia compared to sham treatments, with greater effects observed at lower treatment frequencies.
5 citations
,
July 2023 in “Journal of Diabetes & Metabolic Disorders”
3 citations
,
August 2025 in “Frontiers in Pharmacology” Oral JAK inhibitors are safe for alopecia areata, but baricitinib may cause more acne and infections.
1 citations
,
October 2021 in “Journal of Cosmetic Dermatology” This article's abstract is unavailable and does not provide any new results; readers are advised to contact the corresponding author for more information.
1 citations
,
April 2019 in “Acta medica Philippina” This study found that androgenetic alopecia is significantly associated with an increased risk of Metabolic Syndrome, particularly in early-onset male cases and females exhibiting severe AGA.
June 2026 in “OSF Preprints (OSF Preprints)”
This study found that GLP-1 receptor agonists are linked to a 40% increased risk of non-scarring alopecia in adults, mainly due to weight loss-induced micronutrient deficiencies, with semaglutide and tirzepatide showing the highest hair loss signals.
This study found that GLP-1 receptor agonists are linked to a significant 40% increased risk of non-scarring alopecia, which may result from weight loss-induced micronutrient deficiency.
January 2026 in “Open MIND” This upcoming review will investigate the role of hair follicle fibroblasts in androgenetic alopecia, focusing on their interactions with androgens and impact on cellular signaling and fibrosis.